Publications:  Dr Felice Rivellese

Rivellese F, Pontarini E, Pitzalis C(2020). Tertiary Lymphoid Organs in Rheumatoid Arthritis. Curr Top Microbiol Immunol

Rivellese F, Prediletto E(2020). ACE2 at the centre of COVID-19 from paucisymptomatic infections to severe pneumonia. Autoimmunity Reviews vol. 19, (6)

Nerviani A, Di Cicco M, Mahto A, Lliso-Ribera G, Rivellese F, Thorborn G, Hands R, Bellan M et al.(2020). A Pauci-Immune Synovial Pathotype Predicts Inadequate Response to TNFα-Blockade in Rheumatoid Arthritis Patients. Frontiers in Immunology vol. 11,

Lucchesi D, Coleby R, Pontarini E, Prediletto E, Rivellese F, Hill DG, Derrac Soria A, Jones SA et al.(2020). Impaired IL-27 Mediated Control of CD4+ T Cell Function Impacts on Ectopic Lymphoid Structure Formation in Patients with Sjögren's Syndrome. Arthritis Rheumatol

Rivellese F, Humby F, Bugatti S, Fossati-Jimack L, Rizvi H, Lucchesi D, Lliso-Ribera G, Nerviani A et al. (2020). B CELL-RICH SYNOVITIS IN EARLY AND ESTABLISHED RHEUMATOID ARTHRITIS. RHEUMATOLOGY. vol. 59,

Nerviani A, Lliso-Ribera G, Boutet M-A, Goldmann K, Rivellese F, Kelly S, Bombardieri M, Lewis M et al. (2020). HISTOLOGICAL AND MOLECULAR FEATURES OF THE DISEASED SYNOVIUM IN EARLY UNTREATED PSA IN COMPARISON WITH RA. RHEUMATOLOGY. vol. 59,

Lucchesi D, Coleby R, Pontarini E, Prediletto E, Rivellese F, Hill D, Soria AD, Jones S et al. (2020). IL-27 REGULATES THE MAGNITUDE OF ECTOPIC GERMINAL CENTRES IN EXPERIMENTAL SIALADENITIS BUT FAILS TO MODULATE IL-17 AND IFNG PRODUCTION IN CD4 T CELLS FROM PATIENTS WITH SJOGREN'S SYNDROME. RHEUMATOLOGY. vol. 59,

Humby FC, Lewis M, Durez P, Buch MH, Bombardieri M, Rizvi H, Rivellese F, Fossati L et al. (2020). RANDOMISED, OPEN LABELLED CLINICAL TRIAL TO INVESTIGATE SYNOVIAL MECHANISMS DETERMINING RESPONSE: RESISTANCE TO RITUXIMAB VERSUS TOCILIZUMAB IN RA PATIENTS FAILING TNF INHIBITOR THERAPY. RHEUMATOLOGY. vol. 59, 3-+.

Rivellese F, Humby F, Bugatti S, Fossati-Jimack L, Rizvi H, Lucchesi D, Lliso-Ribera G, Nerviani A et al.(2020). B cell synovitis and clinical phenotypes in rheumatoid arthritis: relationship to disease stages and drug exposure. Arthritis and Rheumatology

Lliso-Ribera G, Humby F, Lewis M, Nerviani A, Mauro D, Rivellese F, Kelly S, Hands R et al.(2019). Synovial tissue signatures enhance clinical classification and prognostic/treatment response algorithms in early inflammatory arthritis and predict requirement for subsequent biological therapy: Results from the pathobiology of early arthritis cohort (PEAC). Annals of the Rheumatic Diseases vol. 78, (12) 1642-1652.

Humby F, Buch MH, Durez P, Lewis M, Bombardieri M, Rizvi H, Kelly S, Fosatti L et al. (2019). A Randomised, Open Labelled Clinical Trial to Investigate Synovial Mechanisms Determining Response - Resistance to Rituximab versus Tocilizumab in Rheumatoid Arthritis Patients Failing TNF Inhibitor Therapy. ARTHRITIS & RHEUMATOLOGY. vol. 71,

Rivellese F, Lliso-Ribera G, Nerviani A, Humby F, Pitzalis C (2019). Persistence of B Cell-rich Synovitis Following Conventional Synthetic Disease Modifying Anti-Rheumatic Drug Treatment in Early Rheumatoid Arthritis Is Associated with Radiographic Progression Independently of Clinical Response. ARTHRITIS & RHEUMATOLOGY. vol. 71,

Lewis MJ, Barnes MR, Blighe K, Goldmann K, Rana S, Hackney JA, Ramamoorthi N, John CR et al.(2019). Molecular Portraits of Early Rheumatoid Arthritis Identify Clinical and Treatment Response Phenotypes. Cell Reports vol. 28, 2455-2470.

Pontarini E, Brown WM, Croia C, Lucchesi D, Rivellese F, Fossati-Jimack L, Ruscitti P, Prediletto E et al. (2019). A UNIQUE IL-21 SIGNATURE CHARACTERIZES LESIONAL AND CIRCULATING T-FOLLICULAR HELPER CELLS IN SJOGREN'S SYNDROME PATIENTS WITH ECTOPIC GERMINAL CENTRES AND MALT LYMPHOMA. ANNALS OF THE RHEUMATIC DISEASES. vol. 78, 221-221.

Rivellese F, Humby F, Bugatti S, Fossati-Jimack L, Rizvi H, Lucchesi D, Ribera GL, Nerviani A et al. (2019). B CELL SYNOVITIS AND CLINICAL PHENOTYPES IN RHEUMATOID ARTHRITIS AT DIFFERENT DISEASE STAGES. ANNALS OF THE RHEUMATIC DISEASES. vol. 78, 296-297.

Nerviani A, Humby F, Ribera GL, Rivellese F, Kelly S, Hands R, Pitzalis C (2019). DEFINING A LEARNING CURVE FOR CLINICIANS PERFORMING ULTRASOUND-GUIDED DEFINING A LEARNING CURVE FOR CLINICIANS PERFORMING ULTRASOUND-GUIDED NEEDLE SYNOVIAL BIOPSIES: A RETROSPECTIVE ANALYSIS OF THE EXPERIENCE AT THE EXPERIMENTAL MEDICINE AND RHEUMATOLOGY, QUEEN MARY UNIVERSITY OF LONDON. ANNALS OF THE RHEUMATIC DISEASES. vol. 78, 317-317.

Lucchesi D, Coleby R, Pontarini E, Prediletto E, Hill D, Soria AD, Rivellese F, Pitzalis C et al. (2019). DENDRITIC CELL-DERIVED IL-27 REGULATES THE MAGNITUDE OF INDUCIBLE ECTOPIC GERMINAL CENTRES BUT FAILS TO DOWNMODULATE IL-17 PRODUCTION IN CD4 T CELLS FROM PATIENTS WITH SJOGREN'S SYNDROME. ANNALS OF THE RHEUMATIC DISEASES. vol. 78, 220-220.

Mauro D, Rivellese F, Manou-Stathopoulou S, Goldmann K, Pyne D, Ciccia F, Pitzalis C, Lewis M (2019). THE EFFECT OF DIMETHYL FUMARATE ON PLASMABLAST DIFFERENTIATION TRANSCRIPTIONAL PROGRAMMES IN SYSTEMIC LUPUS ERYTHEMATOSUS. ANNALS OF THE RHEUMATIC DISEASES. vol. 78, 1077-1077.

Rivellese F, Manou-Stathopoulou S, Mauro D, Pontarini E, Lucchesi D, Congia M, Schafer P, Sutcliffe N et al. (2019). THE TRANSCRIPTION FACTORS IKAROS (IKZF1) AND AIOLOS (IKZF3) ARE EXPRESSED IN THE SALIVARY GLANDS OF SJOGREN'S SYNDROME PATIENTS WITH LYMPHOID AGGREGATES AND MODULATE B CELL ACTIVATION IN VITRO. ANNALS OF THE RHEUMATIC DISEASES. vol. 78, 394-395.

Manou-Stathopoulou S, Rivellese F, Mauro D, Goldmann K, Pyne D, Schafer P, Bombardieri M, Pitzalis C et al. (2019). THE TRANSCRIPTION FACTORS IKZF1 AND IKZF3 CONTROL B CELL ACTIVATION AND DIFFERENTIATION IN SYSTEMIC LUPUS ERYTHEMATOSUS. ANNALS OF THE RHEUMATIC DISEASES. vol. 78, 1548-1548.

Varricchi G, Pecoraro A, Loffredo S, Poto R, Rivellese F, Genovese A, Marone G, Spadaro G(2019). Heterogeneity of human mast cells with respect to MRGPRX2 receptor expression and function. Frontiers in Cellular Neuroscience vol. 13,

Pecoraro A, Crescenzi L, Galdiero MR, Marone G, Rivellese F, Rossi FW, De Paulis A, Genovese A et al.(2019). Immunosuppressive therapy with rituximab in common variable immunodeficiency. Clinical and Molecular Allergy vol. 17, (1)

Rivellese F, Rossi FW, Galdiero MR, Pitzalis C, de Paulis A(2019). Mast cells in early rheumatoid arthritis. International Journal of Molecular Sciences vol. 20, (8)

Varricchi G, Loffredo S, Borriello F, Pecoraro A, Rivellese F, Genovese A, Spadaro G, Marone G(2019). Superantigenic activation of human cardiac mast cells. International Journal of Molecular Sciences vol. 20, (8)

Buonauro A, Sorrentino R, Esposito R, Nappi L, Lobasso A, Santoro C, Rivellese F, Sellitto V et al.(2019). Three-dimensional echocardiographic evaluation of the right ventricle in patients with uncomplicated systemic lupus erythematosus. Lupus vol. 28, (4) 538-544.

Rivellese F, Lobasso A, Barbieri L, Liccardo B, de Paulis A, Rossi FW(2019). Novel therapeutic approaches in rheumatoid arthritis: Role of janus kinases inhibitors. Current Medicinal Chemistry vol. 26, (16) 2823-2843.

Rivellese F, Mauro D, Nerviani A, Pagani S, Fossati-Jimack L, Messemaker T, Kurreeman FAS, Toes REM et al.(2018). Mast cells in early rheumatoid arthritis associate with disease severity and support B cell autoantibody production. Annals of the Rheumatic Diseases vol. 77, (12) 1773-1781.

Bruni C, Frech T, Manetti M, Rossi FW, Furst DE, De Paulis A, Rivellese F, Guiducci S et al.(2018). Vascular Leaking, a Pivotal and Early Pathogenetic Event in Systemic Sclerosis: Should the Door Be Closed?. Frontiers in Immunology vol. 9, 2045-2045.

Rivellese F, Mauro D, Congia M, Pontarini E, Schafer P, Bombardieri M, Pitzalis C, Lewis MJ (2018). Expression and Functions of the Transcription Factors Ikaros and Aiolos in Sjogren's Syndrome and Systemic Lupus Erythematosus. ARTHRITIS & RHEUMATOLOGY. vol. 70,

Nerviani A, Mauro D, Pagani S, Lliso-Ribera G, Rivellese F, Lewis M, Bombardieri M, Humby F et al. (2018). RESTRICTED AXL SYNOVIAL EXPRESSION AND INCREASED CLEAVAGE OF AXL ECTODOMAIN CORRELATE WITH HIGHLY INFLAMED SYNOVITIS AND MORE SEVERE RHEUMATOID ARTHRITIS. ANNALS OF THE RHEUMATIC DISEASES. vol. 77, 255-255.

Rivellese F, Nerviani A, Mauro D, Pagani S, Humby F, Pitzalis C (2018). SYNOVIAL MAST CELLS AND RESPONSES TO SYNTHETIC AND BIOLOGIC DMARDS IN EARLY AND ESTABLISHED RHEUMATOID ARTHRITIS. ANNALS OF THE RHEUMATIC DISEASES. vol. 77, 900-901.

Rivellese F, Congia M, Mauro D, Bombardieri M, Lewis M, Pitzalis C (2018). THE TRANSCRIPTION FACTORS IKAROS AND AIOLOS ARE EXPRESSED IN THE SYNOVIAL MEMBRANE OF EARLY RHEUMATOID ARTHRITIS PATIENTS IN ASSOCIATION WITH SYNOVIAL LYMPHOID AGGREGATES. ANNALS OF THE RHEUMATIC DISEASES. vol. 77, 259-259.

Varricchi G, Raap U, Rivellese F, Marone G, Gibbs BF(2018). Human mast cells and basophils—How are they similar how are they different?. Immunological Reviews vol. 282, (1) 8-34.

Rossi FW, Mercurio V, Rivellese F, Lobasso A, Barbieri L, Tocchetti CG, De Paulis A, Marone G(2018). Severe Aortic Valve Regurgitation in Relapsing Polychondritis. Journal of Clinical Rheumatology vol. 24, (2) 109-111.

Rauber S, Luber M, Weber S, Maul L, Soare A, Wohlfahrt T, Bozec A, Herrmann M et al. (2017). IL-9-Producing Innate Lymphoid Cells - Keyplayers That Orchestrate Resolution of Chronic Inflammation in Arthritis. ARTHRITIS & RHEUMATOLOGY. vol. 69,

Rivellese F, Humby F, Pagani S, Nerviani A, Pitzalis C (2017). Persistence of Mast Cell-Rich Synovitis Is Associated with Lack of Response to Synthetic Disease Modifying Anti-Rheumatic Drugs in Patients with Early Rheumatoid Arthritis. ARTHRITIS & RHEUMATOLOGY. vol. 69,

Nerviani A, Pagani S, Mauro D, Humby F, Kelly S, Rivellese F, Ribera GL, Lewis MJ et al. (2017). Tyrosine Kinase Receptor Axl Is Down Regulated in Highly Inflamed Rheumatoid Synovium and Negatively Correlates with Markers of Disease Activity. ARTHRITIS & RHEUMATOLOGY. vol. 69,

Rauber S, Luber M, Weber S, Maul L, Soare A, Wohlfahrt T, Lin NY, DIetel K et al.(2017). Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cells. Nature Medicine vol. 23, (8) 938-944.

Rivellese F, Nerviani A, Rossi FW, Marone G, Matucci-Cerinic M, de Paulis A, Pitzalis C(2017). Mast cells in rheumatoid arthritis: friends or foes?. Autoimmunity Reviews vol. 16, (6) 557-563.

Rivellese F, Humby F, Nerviani A, Pagani S, Mauro D, de Paulis A, Marone G, Pitzalis C (2017). SYNOVIAL MAST CELLS IDENTIFY PATIENTS WITH A SEVERE PHENOTYPE IN A COHORT OF DMARD NAIVE PATIENTS WITH EARLY RHEUMATOID ARTHRITIS. ANNALS OF THE RHEUMATIC DISEASES. vol. 76, 490-491.

Rossi FW, Lobasso A, Selleri C, Matucci-Cerinic M, Rivellese F, Shoenfeld Y, de Paulis A(2017). Autoimmune tautology in a complex case of poly-autoimmunity: Systemic sclerosis, autoimmune liver involvement, antiphospholipid syndrome and hashimoto’s thyroiditis. Israel Medical Association Journal vol. 19, (3) 193-195.

Marone G, Varricchi G, Loffredo S, Galdiero MR, Rivellese F, De Paulis A(2017). Are Basophils and Mast Cells Masters in HIV Infection?. International Archives of Allergy and Immunology vol. 171, (3-4) 158-165.

Rossi FW, Prevete N, Rivellese F, Lobasso A, Napolitano F, Granata F, Selleri C, de Paulis A(2016). HIV-1 Nef promotes migration and chemokine synthesis of human basophils and mast cells through the interaction with CXCR4. Clinical and Molecular Allergy vol. 14, (15) 1-9.

Rossi FW, Prevete N, Rivellese F, Napolitano F, Montuori N, Postiglione L, Selleri C, de Paulis A(2016). The Urokinase/Urokinase Receptor System in Mast Cells: Effects of its Functional Interaction with fMLF Receptors. Transl Med UniSa vol. 15, 34-41.

Rivellese F, Humby F, Kelly S, de Paulis A, Marone G, Pitzalis C (2016). Synovial Mast Cells Associate with High Disease Activity and Predict Radiographic Progression at 12 Months in Patients with Early Rheumatoid Arthritis. ARTHRITIS & RHEUMATOLOGY. vol. 68,

Rivellese F, Humby F, Kelly S, Nerviani A, Mauro D, Rocher-Ros V, El Shikh ME, de Paulis A et al. (2016). SYNOVIAL MAST CELLS CORRELATE WITH LOCAL AND SYSTEMIC INFLAMMATION AND ARE FUNCTIONALLY ASSOCIATED WITH ECTOPIC LYMPHOID STRUCTURES IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS. Presented at: EULAR 2016,

Rivellese F, Humby F, Kelly S, Rocher V, Pitzalis C (2016). SYNOVIAL MAST CELLS CORRELATE WITH INFLAMMATION AND CELLULAR INFILTRATION AND ARE ASSOCIATED WITH ECTOPIC LYMPHOID STRUCTURES IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS. RHEUMATOLOGY. vol. 55, 89-90.

Llibre A, López-Macías C, Marafioti T, Mehta H, Partridge A, Kanzig C, Rivellese F, Galson JD et al.(2016). LLT1 and CD161 Expression in Human Germinal Centers Promotes B Cell Activation and CXCR4 Downregulation. J Immunol vol. 196, (5) 2085-2094.

Rivellese F, De Paulis A, Marone G, Pitzalis C, Toes REM(2016). Reply. Arthritis and Rheumatology vol. 68, (3) 769-770.

Karkampouna S, Kreulen M, Obdeijn MC, Kloen P, Dorjée AL, Rivellese F, Chojnowski A, Clark I et al.(2016). Connective Tissue Degeneration: Mechanisms of Palmar Fascia Degeneration (Dupuytren's Disease). Curr Mol Biol Rep vol. 2, (3) 133-140.

Suurmond J, Rivellese F, Dorjée AL, Bakker AM, Rombouts YJPC, Rispens T, Wolbink G, Zaldumbide A et al.(2015). Toll-like receptor triggering augments activation of human mast cells by anti-citrullinated protein antibodies. Annals of the Rheumatic Diseases vol. 74, (10) 1915-1923.

Rivellese F, Suurmond J, Habets K, Dorjee AL, de Paulis A, Marone G, Pitzalis C, Huizinga TW et al. (2015). HUMAN MAST CELLS STIMULATED WITH IL-33 AND IMMUNE COMPLEXES DOWN-REGULATE MONOCYTE ACTIVATION IN RHEUMATOID ARTHRITIS. ANNALS OF THE RHEUMATIC DISEASES. vol. 74, 201-201.

Rivellese F, Suurmond J, Habets K, Dorjée AL, Ramamoorthi N, Townsend MJ, De Paulis A, Marone G et al.(2015). Ability of interleukin-33- and immune complex-triggered activation of human mast cells to down-regulate monocyte-mediated immune responses. Arthritis and Rheumatology vol. 67, (9) 2343-2353.

Rivellese F, Suurmond J, de Paulis A, Marone G, Huizinga TWJ, Toes REM(2014). IgE and IL-33-mediated triggering of human basophils inhibits TLR4-induced monocyte activation. Eur J Immunol vol. 44, (10) 3045-3055.

Rivellese F, Suurmond J, de Paulis A, Marone G, Huizinga TW, Toes REM (2014). Human basophils modulate monocyte activation. ALLERGY. vol. 69, 59-59.

Del Mastro A, Pelosi C, Lobasso A, Rivellese F, Genovese A, de Paulis A, Marone G (2014). Macrophagic activation syndrome in adult-onset Still's disease: report of a complex case. ALLERGY. vol. 69, 471-472.

Suurmond J, Rivellese F, Dorjée AL, Bakker AM, Rombouts YJPC, Rispens T, Wolbink G, Zaldumbide A et al.(2014). Toll-like receptor triggering augments activation of human mast cells by anti-citrullinated protein antibodies. Annals of the Rheumatic Diseases

Suurmond J, Stoop JN, Rivellese F, Bakker AM, Huizinga TWJ, Toes REM(2014). Activation of human basophils by combined toll-like receptor- and FcεRI-triggering can promote Th2 skewing of naive T helper cells. European Journal of Immunology vol. 44, (2) 386-396.

Rivellese F, Suurmond J, de Paulis A, Marone G, Huizinga TWJ, Toes REM(2014). IgE and IL-33-mediated triggering of human basophils inhibits TLR4-induced monocyte activation. European Journal of Immunology vol. 44, (10) 3045-3055.

Rivellese F, Prevete N, Rossi FW, Lamacchia D, Pelosi C, Marone G, de Paulis A (2013). EXPRESSION AND FUNCTIONS OF VASCULAR ENDOTHELIAL GROWTH FACTOR AND ANGIOPOIETIN RECEPTORS IN HUMAN SYNOVIAL MAST CELLS. ANNALS OF THE RHEUMATIC DISEASES. vol. 71, 321-321.

Prevete N, Rossi FW, Rivellese F, Lamacchia D, Pelosi C, Lobasso A, Necchi V, Solcia E et al.(2013). Helicobacter pylori HP(2-20) induces eosinophil activation and accumulation in superficial gastric mucosa and stimulates VEGF-α and TGF-β release by interacting with formyl-peptide receptors. International Journal of Immunopathology and Pharmacology vol. 26, (3) 647-662.

Cioffi A, Siani MC, Rivellese F, Spadaro G, Genovese A(2012). Drug hypersensitivity reactions. Part II. Extra-cutaneous manifestations. Italian Journal of Allergy and Clinical Immunology vol. 22, (3-4) 45-54.

Spadaro G, Squeglia V, Pecoraro A, Galdiero M, Gravante C, Rivellese F, Marone G, Genovese A (2012). Heart failure in Churg-Strauss Syndrome: a case responsive to high-dose intravenous immunoglobulins therapy. ALLERGY. vol. 67, 559-560.

Prevete N, Salzano FA, Rossi FW, Rivellese F, Dellepiane M, Guastini L, Mora R, Marone G et al.(2011). Role(s) of formyl-peptide receptors expressed in nasal epithelial cells. Journal of Biological Regulators and Homeostatic Agents vol. 25, (4) 553-564.

Prevete N, Rossi F, Salerno F, Rivellese F, Salami A, Salzano F, Marone G, de Paulis A (2010). Role of formyl-peptide receptors expressed on nasal epithelial cells in chronic rhinosinusitis. ALLERGY. vol. 65, 119-119.

Rossi F, Baldissara M, Prevete N, Rivellese F, Pirozzi F, Bonaduce D, De Paulis A, Marone G (2010). Role of the TDI-echocardiography in cardiac evaluation of patients with autoimmune diseases. ALLERGY. vol. 65, 113-113.

De Paulis A, Prevete N, Rossi FW, Rivellese F, Salerno F, Delfino G, Liccardo B, Avilla E et al.(2009). Helicobacter pylori Hp(2-20) promotes migration and proliferation of gastric epithelial cells by interacting with formyl peptide receptors in vitro and accelerates gastric mucosal healing in vivo. Journal of Immunology vol. 183, (6) 3761-3769.

Romano M, Prevete N, Rossi FW, Rivellese F, Salerno F, Delfino G, Liccardo B, Staibano S et al. (2009). H. pylori Peptide HP(2-20) Promotes Healing of Injured Gastric Mucosa By Interacting with Formyl-Peptyde Receptors. GASTROENTEROLOGY. vol. 136, A103-A103.

Prevete N, Delfino G, Rivellese F, Rossi F, Liccardo B, Marone G, de Paulis A (2008). Pleiotropic roles of formyl-peptide receptors expressed on human basophils. ALLERGY. vol. 63, 30-30.